These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 1324317

  • 21. WY-50,295 tromethamine, a novel, orally active 5-lipoxygenase inhibitor: biochemical characterization and antiallergic activity.
    Grimes D, Sturm RJ, Marinari LR, Carlson RP, Berkenkopf JW, Musser JH, Kreft AF, Weichman BM.
    Eur J Pharmacol; 1993 May 19; 236(2):217-28. PubMed ID: 8391458
    [Abstract] [Full Text] [Related]

  • 22. Quinolines as potent 5-lipoxygenase inhibitors: synthesis and biological profile of L-746,530.
    Dubé D, Blouin M, Brideau C, Chan CC, Desmarais S, Ethier D, Falgueyret JP, Friesen RW, Girard M, Girard Y, Guay J, Riendeau D, Tagari P, Young RN.
    Bioorg Med Chem Lett; 1998 May 19; 8(10):1255-60. PubMed ID: 9871745
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Guinea pig whole blood 5-lipoxygenase assay: utility in the assessment of potential 5-lipoxygenase inhibitors.
    Spaethe SM, Snyder DW, Pechous PA, Clarke T, VanAlstyne EL.
    Biochem Pharmacol; 1992 Jan 22; 43(2):377-82. PubMed ID: 1310855
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The properties of A-69412: a small hydrophilic 5-lipoxygenase inhibitor.
    Bell RL, Bouska J, Young PR, Lanni C, Machinist J, Malo PE, Summers JB, Brooks DW, Carter GW.
    Agents Actions; 1993 Mar 22; 38(3-4):178-87. PubMed ID: 8213344
    [Abstract] [Full Text] [Related]

  • 29. Nonsteroidal anti-inflammatory drugs as scaffolds for the design of 5-lipoxygenase inhibitors.
    Kolasa T, Brooks CD, Rodriques KE, Summers JB, Dellaria JF, Hulkower KI, Bouska J, Bell RL, Carter GW.
    J Med Chem; 1997 Feb 28; 40(5):819-24. PubMed ID: 9057869
    [Abstract] [Full Text] [Related]

  • 30. Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: biochemical assessment in vitro and ex vivo.
    Tateson JE, Randall RW, Reynolds CH, Jackson WP, Bhattacherjee P, Salmon JA, Garland LG.
    Br J Pharmacol; 1988 Jun 28; 94(2):528-39. PubMed ID: 2840160
    [Abstract] [Full Text] [Related]

  • 31. Inhibition of leukotriene formation in human leukocytes by halothane.
    Yamaoka A, Sumimoto H, Takeshige K, Itoh T, Isobe R, Yoshitake J, Minakami S.
    Biochim Biophys Acta; 1987 Apr 24; 918(3):284-92. PubMed ID: 3032266
    [Abstract] [Full Text] [Related]

  • 32. [Pyrrolo(2,3-c)quinolines and pyrrolo(3,4-d)quinolines--synthesis and investigation of lipoxygenase inhibition].
    Görlitzer K, Fabian J, Frohberg P, Drutkowski G.
    Pharmazie; 2002 Apr 24; 57(4):243-9. PubMed ID: 11998442
    [Abstract] [Full Text] [Related]

  • 33. Naphthalenic lignan lactones as selective, nonredox 5-lipoxygenase inhibitors. Synthesis and biological activity of (methoxyalkyl)thiazole and methoxytetrahydropyran hybrids.
    Ducharme Y, Brideau C, Dubé D, Chan CC, Falgueyret JP, Gillard JW, Guay J, Hutchinson JH, McFarlane CS, Riendeau D.
    J Med Chem; 1994 Feb 18; 37(4):512-8. PubMed ID: 8120869
    [Abstract] [Full Text] [Related]

  • 34. 5-Lipoxygenase inhibitors: synthesis and structure-activity relationships of a series of 1-aryl-2H,4H-tetrahydro-1,2,4-triazin-3-ones.
    Bhatia PA, Brooks CD, Basha A, Ratajczyk JD, Gunn BP, Bouska JB, Lanni C, Young PR, Bell RL, Carter GW.
    J Med Chem; 1996 Sep 27; 39(20):3938-50. PubMed ID: 8831760
    [Abstract] [Full Text] [Related]

  • 35. In vivo characterization of hydroxamic acid inhibitors of 5-lipoxygenase.
    Summers JB, Gunn BP, Mazdiyasni H, Goetze AM, Young PR, Bouska JB, Dyer RD, Brooks DW, Carter GW.
    J Med Chem; 1987 Nov 27; 30(11):2121-6. PubMed ID: 3669019
    [Abstract] [Full Text] [Related]

  • 36. Studies on 5-lipoxygenase inhibitors. I. Synthesis and 5-lipoxygenase-inhibitory activity of novel hydroxamic acid derivatives.
    Yatabe T, Kawai Y, Oku T, Tanaka H.
    Chem Pharm Bull (Tokyo); 1998 Jun 27; 46(6):966-72. PubMed ID: 9658575
    [Abstract] [Full Text] [Related]

  • 37. Anti-inflammatory activity of a potent, selective leukotriene A4 hydrolase inhibitor in comparison with the 5-lipoxygenase inhibitor zileuton.
    Rao NL, Dunford PJ, Xue X, Jiang X, Lundeen KA, Coles F, Riley JP, Williams KN, Grice CA, Edwards JP, Karlsson L, Fourie AM.
    J Pharmacol Exp Ther; 2007 Jun 27; 321(3):1154-60. PubMed ID: 17371808
    [Abstract] [Full Text] [Related]

  • 38. Lipoxygenase inhibitors, Part 6. Synthesis of new tetrahydropyrazine and other heterocyclic compounds by reaction of hydrazonoyl chlorides.
    Frohberg P, Wiese M, Nuhn P.
    Arch Pharm (Weinheim); 1997 Mar 27; 330(3):47-52. PubMed ID: 9167446
    [Abstract] [Full Text] [Related]

  • 39. 4-acylaminophenol derivatives as novel lipoxygenase inhibitors: synthesis and inhibitory effect on 5-lipoxygenase and leukotriene B4 production.
    Kikuchi M, Hashimura Y, Tsuzurahara K, Nagasawa M, Inoue H, Taniguchi T, Uchida T.
    Biol Pharm Bull; 1994 Aug 27; 17(8):1038-46. PubMed ID: 7820104
    [Abstract] [Full Text] [Related]

  • 40. Ca2+ ionophore A23187-stimulated secretion of azurophil granules in human polymorphonuclear leukocytes is largely mediated by endogenously formed leukotriene B4.
    Hatzelmann A, Fruchtmann R, Mohrs KH, Raddatz S, Müller-Peddinghaus R.
    Biochem Pharmacol; 1994 Jul 05; 48(1):31-9. PubMed ID: 8043028
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.